| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.0M | — | — |
| Cost of Revenue | $2.0M | — | — |
| Gross Profit | $13K | — | — |
| R&D Expense | $1.2M | +11.5% | -48.6% |
| SG&A Expense | $1.3M | -12.4% | +50.4% |
| Operating Income | -$2.4M | +2.5% | +21.4% |
| Pre-tax Income | $59.5M | +352.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $52.2M | +230.3% | — |
| Short-term Investments | $5.0M | +182.7% | -91.4% |
| Current Assets | $136.1M | +37.5% | -4.7% |
| Total Assets | $220.5M | +36.4% | +33.6% |
| Current Liabilities | $6.1M | +65.7% | +16.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.7M | — | — |
| Capital Expenditures | $7K | — | — |
| Investing Cash Flow | $7.1M | — | — |
| Financing Cash Flow | -$732K | — | — |
| Free Cash Flow | -$8.7M | — | — |
| +421.2% |
| Income Tax | $11.1M | +8879.4% | +876.3% |
| Net Income | $48.4M | +264.2% | +346.7% |
| EPS (Basic) | $1.16 | +262.5% | +341.7% |
| EPS (Diluted) | $1.13 | +264.5% | +335.4% |
| $203.3M |
| +31.5% |
| +29.9% |